Monitoring antiepileptic drugs

A level-headed approach

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Despite advances in epilepsy therapeutics, some physicians feel uncomfortable with newer antiepileptic drugs (AEDs) due to difficulty in promptly obtaining blood levels to guide medication adjustment, and even when levels for newer AEDs are obtained, many practitioners feel they are not very useful. Lacking confidence in AEDs whose levels that cannot readily or expeditiously be measured, many clinicians share uncertainty about proper use of the newer AEDs and monitoring AED administration. Similarly, some epilepsy patients inflate the importance of AED blood level monitoring, feeling that blood levels falling within traditionally therapeutic ranges are a fail-safe for seizure control, regardless of their compliance or personal behavior aggravating seizure burden, such as poor sleep or use of illicit substances. This review examines the elusive concept of therapeutic AED blood levels and potential uses and abuses of blood level monitoring, reinforcing appropriate uses for blood levels to ensure compliance and adjust for altered AED pharmacokinetics in the context of aging and disease states, pregnancy, or drug interactions.

Original languageEnglish (US)
Pages (from-to)115-119
Number of pages5
JournalCurrent Neuropharmacology
Volume7
Issue number2
DOIs
StatePublished - 2009

Fingerprint

Anticonvulsants
Compliance
Epilepsy
Seizures
Social Adjustment
Drug Monitoring
Drug Interactions
Uncertainty
Sleep
Emotions
Therapeutics
Pharmacokinetics
Physicians
Pregnancy

Keywords

  • Antiepileptic drugs
  • Blood levels
  • Epilepsy
  • Monitoring

ASJC Scopus subject areas

  • Clinical Neurology
  • Pharmacology (medical)
  • Psychiatry and Mental health
  • Neurology
  • Pharmacology

Cite this

Monitoring antiepileptic drugs : A level-headed approach. / St Louis, Erik K.

In: Current Neuropharmacology, Vol. 7, No. 2, 2009, p. 115-119.

Research output: Contribution to journalArticle

@article{46b7dd7376d04e268f3f762b449cc378,
title = "Monitoring antiepileptic drugs: A level-headed approach",
abstract = "Despite advances in epilepsy therapeutics, some physicians feel uncomfortable with newer antiepileptic drugs (AEDs) due to difficulty in promptly obtaining blood levels to guide medication adjustment, and even when levels for newer AEDs are obtained, many practitioners feel they are not very useful. Lacking confidence in AEDs whose levels that cannot readily or expeditiously be measured, many clinicians share uncertainty about proper use of the newer AEDs and monitoring AED administration. Similarly, some epilepsy patients inflate the importance of AED blood level monitoring, feeling that blood levels falling within traditionally therapeutic ranges are a fail-safe for seizure control, regardless of their compliance or personal behavior aggravating seizure burden, such as poor sleep or use of illicit substances. This review examines the elusive concept of therapeutic AED blood levels and potential uses and abuses of blood level monitoring, reinforcing appropriate uses for blood levels to ensure compliance and adjust for altered AED pharmacokinetics in the context of aging and disease states, pregnancy, or drug interactions.",
keywords = "Antiepileptic drugs, Blood levels, Epilepsy, Monitoring",
author = "{St Louis}, {Erik K}",
year = "2009",
doi = "10.2174/157015909788848938",
language = "English (US)",
volume = "7",
pages = "115--119",
journal = "Current Neuropharmacology",
issn = "1570-159X",
publisher = "Bentham Science Publishers B.V.",
number = "2",

}

TY - JOUR

T1 - Monitoring antiepileptic drugs

T2 - A level-headed approach

AU - St Louis, Erik K

PY - 2009

Y1 - 2009

N2 - Despite advances in epilepsy therapeutics, some physicians feel uncomfortable with newer antiepileptic drugs (AEDs) due to difficulty in promptly obtaining blood levels to guide medication adjustment, and even when levels for newer AEDs are obtained, many practitioners feel they are not very useful. Lacking confidence in AEDs whose levels that cannot readily or expeditiously be measured, many clinicians share uncertainty about proper use of the newer AEDs and monitoring AED administration. Similarly, some epilepsy patients inflate the importance of AED blood level monitoring, feeling that blood levels falling within traditionally therapeutic ranges are a fail-safe for seizure control, regardless of their compliance or personal behavior aggravating seizure burden, such as poor sleep or use of illicit substances. This review examines the elusive concept of therapeutic AED blood levels and potential uses and abuses of blood level monitoring, reinforcing appropriate uses for blood levels to ensure compliance and adjust for altered AED pharmacokinetics in the context of aging and disease states, pregnancy, or drug interactions.

AB - Despite advances in epilepsy therapeutics, some physicians feel uncomfortable with newer antiepileptic drugs (AEDs) due to difficulty in promptly obtaining blood levels to guide medication adjustment, and even when levels for newer AEDs are obtained, many practitioners feel they are not very useful. Lacking confidence in AEDs whose levels that cannot readily or expeditiously be measured, many clinicians share uncertainty about proper use of the newer AEDs and monitoring AED administration. Similarly, some epilepsy patients inflate the importance of AED blood level monitoring, feeling that blood levels falling within traditionally therapeutic ranges are a fail-safe for seizure control, regardless of their compliance or personal behavior aggravating seizure burden, such as poor sleep or use of illicit substances. This review examines the elusive concept of therapeutic AED blood levels and potential uses and abuses of blood level monitoring, reinforcing appropriate uses for blood levels to ensure compliance and adjust for altered AED pharmacokinetics in the context of aging and disease states, pregnancy, or drug interactions.

KW - Antiepileptic drugs

KW - Blood levels

KW - Epilepsy

KW - Monitoring

UR - http://www.scopus.com/inward/record.url?scp=70349705741&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349705741&partnerID=8YFLogxK

U2 - 10.2174/157015909788848938

DO - 10.2174/157015909788848938

M3 - Article

VL - 7

SP - 115

EP - 119

JO - Current Neuropharmacology

JF - Current Neuropharmacology

SN - 1570-159X

IS - 2

ER -